BioPharmSignal logoBioPharmSignal

Biotech News

Viracta Therapeutics Announces Wind Down of Operations

Viracta Therapeutics (VIRX)Viracta TherapeuticsCompany update

VIRX (VIRX) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is virx.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

KYMRKymera2026-06-08 20:01 EST

Kymera Therapeutics Appoints Penny Carlson as Senior Vice President, Development Operations

MGNXMacroGenics2026-07-02 13:25 EST

MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals

View all latest news

Viracta Therapeutics

Viracta Therapeutics is an oncology company focused on virus-associated cancers and targeted cancer biology. Its platform aims to treat tumors linked to latent viral drivers.

Recent company news

VIRXViracta Therapeutics2025-02-05 22:00 EST

Viracta Therapeutics Announces Wind Down of Operations

VIRXViracta Therapeutics2024-12-26 21:30 EST

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

VIRXViracta Therapeutics2024-11-13 12:00 EST

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

VIRXViracta Therapeutics2024-11-06 20:19 EST

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

VIRXViracta Therapeutics2024-09-05 15:32 EST

Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States